| 16-May-13 08:00PM | Neurocrine Biosciences' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) at Seeking Alpha |
| 10-May-13 01:37PM | A Look At Neurocrine's VMAT-2 Inhibitor As Phase IIb Data Nears at Seeking Alpha |
| 01:04PM | NEUROCRINE BIOSCIENCES INC Financials EDGAR Online Financials |
| 09-May-13 03:00PM | Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference PR Newswire |
| 07-May-13 05:00AM | Neurocrine Biosciences Inc. Stock Downgraded (NBIX) at TheStreet |
| 04-May-13 05:22PM | 1 Winner and 4 Losers from This Weeks Earnings Storm at Wall St. Cheat Sheet |
| 03-May-13 11:31PM | Neurocrine Biosciences CEO Discuses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 02-May-13 07:25PM | Neurocrine Biosciences Earnings: Heres Why Investors are Selling Shares Now at Wall St. Cheat Sheet |
| 04:24PM | InPlay: Neurocrine Biosci reports EPS in-line, misses on revs Briefing.com |
| 04:02PM | Neurocrine Biosciences Reports First Quarter 2013 Results PR Newswire |
| 09:19AM | NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 07:07AM | Q1 2013 Neurocrine Biosciences Earnings Release - After Market Close CCBN |
| 30-Apr-13 11:18AM | Wall Street Transcript Interview with Ian Somaiya, Managing Director and Senior Research Analyst at Piper Jaffray & Co.: Identifying Hidden Value and Market Opportunities in Biotech Companies Wall Street Transcript |
| 26-Apr-13 01:00PM | Neurocrine Biosciences Announces Conference Call And Webcast To Present First Quarter 2013 Financial Results PR Newswire |
| 24-Apr-13 01:00PM | Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference PR Newswire |
| 18-Apr-13 01:32PM | 2 Pharmaceutical Buys Under $15 With Strong Catalysts at Seeking Alpha |
| 11-Apr-13 01:07PM | San Diego: The New Silicon Valley of Biotechnology? at CNBC |
| 09-Apr-13 03:45AM | Neurocrine draws nervous position optionMONSTER |
| 03:23AM | Neurocrine draws nervous position optionMONSTER |
| 02:53AM | Neurocrine draws nervous position optionMONSTER |
| 08-Apr-13 05:35PM | VIX - Options Volatility And Market Sonar: Monday Recap at Seeking Alpha |
| 04-Apr-13 12:51PM | 3 Stocks Near 52-Week Highs Worth Selling at Motley Fool |
| 27-Mar-13 07:00AM | Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids PR Newswire |
| 25-Mar-13 08:06AM | Drug Manufacturing Companies Emphasize R&D Efforts Accesswire |
| 21-Mar-13 09:56AM | How Safe is AbbVie from Niacins Woes? at Motley Fool |
| 11-Mar-13 03:44PM | A Quick Look At 8 Biotechs Ready To Gain Momentum at Seeking Alpha |
| 11:00AM | Neurocrine Biosciences To Present At The 25th Annual Roth Conference PR Newswire |
| 27-Feb-13 11:00AM | Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference PR Newswire |
| 14-Feb-13 01:04PM | NEUROCRINE BIOSCIENCES INC Financials EDGAR Online Financials |
| 12-Feb-13 04:04AM | Neurocrine Biosciences Inc. Stock Upgraded (NBIX) at TheStreet |
| 11-Feb-13 05:44PM | New Star Analyst Rankings for Neurocrine Biosciences, Inc. StarMine |
| 10-Feb-13 08:09PM | Orbital Sciences Announces Successful Satellite Launch and 3 Stocks Enjoying 52-Week Highs at Wall St. Cheat Sheet |
| 02:53PM | New Star Analyst Rankings for Neurocrine Biosciences, Inc. StarMine |
| 09-Feb-13 02:56PM | 2 Rising Healthcare Stocks to Watch Now at Wall St. Cheat Sheet |
| 11:22AM | 3 Humongous Health-Care Stocks This Week at Motley Fool |
| 08-Feb-13 05:02PM | LinkedIn, AOL, Coinstar are market movers AP +5.96% |
| 02:08PM | Neurocrine Biosciences' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 12:36PM | Neurocrine 4Q profit jumps due to collaboration AP |
| 10:43AM | Neurocrine Biosciences Earnings: Heres Why Shares are Popping Higher Now at Wall St. Cheat Sheet |
| 07:32AM | NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 07:07AM | Q4 2012 Neurocrine Biosciences Earnings Release - Before Market Open CCBN |
| 07:00AM | Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results PR Newswire |
| 06-Feb-13 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 02:07PM | Nasdaq stocks posting largest percentage increases AP |
| 11:00AM | Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013 PR Newswire |
| 08:20AM | Biotech Companies Attractive Targets for Pharmaceutical Companies Looking to Replace Lost Revenues Marketwire |
| 05-Feb-13 06:06PM | Nasdaq stocks posting largest percentage increases AP +12.29% |
| 01:16PM | Nasdaq stocks posting largest percentage increases AP |
| 01-Feb-13 03:33PM | Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results PR Newswire |
| 24-Jan-13 08:32AM | 4 Healthcare Stock Stories Prescribed for Investors at Wall St. Cheat Sheet |
| 23-Jan-13 04:12PM | InPlay: Neurocrine Biosci announces additional European and US patents issued on proprietary vmat2 inhibitor Briefing.com |
| 04:05PM | Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor PR Newswire |
| 14-Jan-13 04:08PM | NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 07-Jan-13 10:04AM | Neurocrine Biosciences: Elagolix-Channel Checks And Expert Opinion Reveal Small Market Size, Unfavorable Incentives at Seeking Alpha |
| 18-Dec-12 04:14PM | InPlay: Neurocrine Biosci announces start of second Phase IIb study of VMAT2 Inhibitor NBI-98854 for treatment Of Tardive Dyskinesia Briefing.com |
| 04:12PM | Neurocrine Announces Start Of Second Phase IIb Study Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia PR Newswire |
| 04-Dec-12 04:44PM | Neurocrine Biosciences Presents at Deutsche Bank's 2012 dbAccess BioFEST (Transcript) at Seeking Alpha |
| 27-Nov-12 05:00PM | Neurocrine Biosciences To Present At Deutsche Bank's 2012 dbAccess BioFEST PR Newswire |
| 20-Nov-12 05:00PM | Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference PR Newswire |
| 13-Nov-12 03:16PM | Neurocrine Biosciences' CEO Presents at Lazard Capital Market's 9th Annual Healthcare Conference (Transcript) at Seeking Alpha |
| 07-Nov-12 08:50PM | The Most Promising Dividends in Pharmaceutical Companies at Motley Fool |
| 04:00AM | Neurocrine Biosciences Inc. Stock Downgraded (NBIX) at TheStreet |
| 06-Nov-12 01:04PM | NEUROCRINE BIOSCIENCES INC Financials EDGAR Online Financials |
| 01:00PM | Neurocrine Biosciences To Present At Lazard Capitalmarket's 9th Annual Healthcare Conference PR Newswire |
| 01-Nov-12 11:15AM | PropThink: Sizing Up Elagolix - A Blockbuster Drug Thomson Reuters ONE |
| 09:41AM | New Star Analyst Rankings for Neurocrine Biosciences, Inc. StarMine |
| 31-Oct-12 11:25PM | Neurocrine Biosciences' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 05:39PM | Neurocrine posts 3Q loss from profit a year ago AP |
| 05:15PM | Neurocrine Biosciences Earnings: Swings to a Loss, Falling Short of Estimates at Wall St. Cheat Sheet |
| 04:37PM | Neurocrine Biosciences Earnings: Swings to a Loss, Falling Short of Estimates at Wall St. Cheat Sheet |
| 04:11PM | NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 04:09PM | InPlay: Neurocrine Biosci misses by $0.01, misses on revs Briefing.com |
| 04:02PM | Neurocrine Biosciences Reports Third Quarter 2012 Results PR Newswire |
| 07:07AM | Q3 2012 Neurocrine Biosciences Earnings Release - After Market Close CCBN |
| 24-Oct-12 05:52PM | Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results PR Newswire |
| 08-Oct-12 02:57PM | Need An Alternative To Stocks Like Merck And Abbott Labs? Try Neurocrine Biosciences at Seeking Alpha |
| 04-Oct-12 09:25AM | New Stock Coverage: TripAdvisor Going Places at Minyanville |
| 03-Oct-12 04:45PM | After-Hours Buzz: MAR, AMAT, NUVA & More at CNBC |
| 02-Oct-12 05:20PM | Merck Finds Gardisil To Be Safe In The Short Term and 2 Other Companies Continue Drug Trials at Wall St. Cheat Sheet |
| 03:32PM | Neurocrine's VMAT-2 Enters Phase IIb at Seeking Alpha |
| 03:18PM | 5 Small Cap, Low-Debt Stocks Projected For Growth at Seeking Alpha |
| 07:22AM | Healthcare Business Review: GenVecs Conference Success, Neurocrine Begins Trials at Wall St. Cheat Sheet |
| 01-Oct-12 10:32PM | Healthcare Business Roundup: GenVecs Conference Success, Neurocrine Begins Trials at Wall St. Cheat Sheet |
| 06:59PM | Healthcare Business Roundup: GenVecs Conference Success, Neurocrine Begins Trials at Wall St. Cheat Sheet |
| 04:07PM | InPlay: Neurocrine Biosci Announces Start Of Phase IIb Study Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia Briefing.com |
| 04:05PM | Neurocrine Announces Start Of Phase IIb Study Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia PR Newswire |
| 18-Sep-12 05:15PM | Neurocrine Still Looks Significantly Underrated at Seeking Alpha |
| 04:24PM | NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online |
| 12-Sep-12 12:55PM | Neurocrine Biosciences' Management Presents at Morgan Stanley Global Healthcare Conference - Transcript at Seeking Alpha |
| 12:50AM | 2-Star Stocks Poised to Plunge: Neurocrine Biosciences? at Motley Fool |
| 05-Sep-12 05:18PM | Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference PR Newswire |
| 01-Sep-12 07:38AM | Four Important Biotech Stocks Targeting Unmet Needs at Motley Fool |
| 23-Aug-12 01:39PM | Why M&A Flurry Has Top MKM Analyst Smiling All The Way To The Bank at Seeking Alpha |
| 21-Aug-12 02:50PM | 3 Small Cap Stocks With Growth On The Horizon That Are Churning Out Profits at Seeking Alpha |
| 07-Aug-12 01:04PM | NEUROCRINE BIOSCIENCES INC Financials EDGAR Online Financials |
| 01-Aug-12 10:16AM | Equity Briefing: Upgrades and Downgrades for August 01st: CNI, CYTK, DAL, DISCA, DRIV, FHN, FIRE, HBI, HPY, IN Thomson Reuters ONE -7.89% |
| 09:15AM | New Stock Coverage: Boeing Stuck in Holding Pattern at Minyanville |
| 09:00AM | NBIX: Remaining Optimistic On Neurocrine Bio Zacks Small Cap Research |
| 31-Jul-12 09:25PM | Neurocrine Biosciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 05:22PM | Neurocrine Biosciences Earnings: Mixed Results at Wall St. Cheat Sheet |
